See news from the full history of Samplix, covering all the conferences we've attended, new product launches, and more.
December 17-18
In the agenda: Xdrop Technology for targeted enrichment of genomic regions for long- and short-read sequencing. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
4-6 November
Samplix demonstrated our recently launched Xdrop system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg, Germany.
November 7-8
Samplix demonstrated our recently launched Xdrop system at the Oxford Global 11th Annual NGS & Clinical Diagnostics Congress in London, UK.
November 13-14
We attended at the Genomic Medicine 2019 Nordic conference at Kennedy Center at Rigshospitalet in Copenhagen, Denmark.
November 20-21
We attended at the Genomic Medicine 2019 Cambridge conference at Murray Edwards College in Cambridge, UK.
September 2, 2019
Today, Samplix happily announced the commercial launch of our Xdrop instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.
Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.
The types of genomic regions that are now unlocked by the Xdrop technology include:
Today, Samplix announced the commercial launch of its Xdrop sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
To read more, please see the full press release here:
January 2019. Samplix is pleased to announce that the company was selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.
Samplix’ proprietary Xdrop technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.
The Xdrop technology is currently in beta test at leading research institutions world-wide.
“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop solution later this year” said CEO Lars Kongsbak.
To read more about Horizon 2020 SME awards, please visit European Commission website:
